Nicholas C. Verity
Edinburgh, SCT EH164TJ, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Intercellular transport of miR-146a from macrophages to vascular smooth muscle cells: a novel mechanism and therapeutic target for atherosclerosis.
Journal: Cardiovascular research
Published: May 08, 2026
Cell adhesion molecule CD44 is dispensable for reactive astrocyte activation during prion disease.
Journal: Scientific reports
Published: February 22, 2024
Excess ribosomal protein production unbalances translation in a model of Fragile X Syndrome.
Journal: Nature communications
Published: September 27, 2021
TrkB signaling regulates the cold-shock protein RBM3-mediated neuroprotection.
Journal: Life science alliance
Published: August 22, 2020
Repurposed drugs targeting eIF2α-P-mediated translational repression prevent neurodegeneration in mice.
Journal: Brain : a journal of neurology
Published: October 18, 2016
M1 muscarinic allosteric modulators slow prion neurodegeneration and restore memory loss.
Journal: The Journal of clinical investigation
Published: March 11, 2016
PERK inhibition prevents tau-mediated neurodegeneration in a mouse model of frontotemporal dementia.
PERK inhibition prevents tau-mediated neurodegeneration in a mouse model of frontotemporal dementia.
Journal: Acta neuropathologica
Published: August 26, 2015
Partial restoration of protein synthesis rates by the small molecule ISRIB prevents neurodegeneration without pancreatic toxicity.
Journal: Cell death & disease
Published: January 09, 2015
Oral treatment targeting the unfolded protein response prevents neurodegeneration and clinical disease in prion-infected mice.
Journal: Science translational medicine
Published: October 11, 2013
Last Updated: 09/26/2026